skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Sunday, June 7, 2020

COVID-19 - How To Protect Yourself And Others - CDC.gov

The pandemic is not over yet!


The CDC tells us:

How to Protect Yourself & Others



Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 5:57 AM
Labels: cdc, COVID, guidelines, recommendations

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course

SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2025 #2026 #2027

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2025

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2025 #2026 #2027

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • Food Poison Journal
    Pasta Listeria Outbreak over after 28 sick in 19 states with 7 dead
    5 hours ago
  • Wellness Blog - NY Times
    Measles Outbreak Hits Ave Maria University in Florida
    6 hours ago
  • Government Executive
    OPM instructs agencies to terminate union contracts potentially in violation of court orders
    8 hours ago
  • Medscape Today Headlines
    Benefits of TrumpRx Drug Site Are Limited, Experts Say
    8 hours ago
  • eLearning Industry
    Common Employee Development Challenges And How To Overcome Them
    10 hours ago
  • FierceBiotech: Medtech
    FDA clears Encora Therapeutics’ wearable wrist device for essential tremor
    10 hours ago
  • All Kaiser Health News
    ACA Subsidies Expired. Open Enrollment Ended. But It Will Still Take Awhile To Register the Results.
    10 hours ago
  • BioPharma Dive - Latest News
    Vertex’s CRISPR therapy rebounds in latest earnings
    12 hours ago
  • BioPharma Dive
    Vertex’s CRISPR therapy rebounds in latest earnings
    12 hours ago
  • Medtech Insight
    SEISMIC Potential: Minimally Invasive Brain Surgery Project Shows Scope Of EU IHI Funding
    13 hours ago
  • Pharmaceutical Commerce
    14 hours ago
  • Pharmalot – STAT
    STAT+: Up and down the ladder: The latest comings and goings
    14 hours ago
  • Clarkston Consulting
    How Food Brands Are Rethinking Pricing and Value to Meet Today’s Consumer
    16 hours ago
  • FierceBiotech
    FDA rejects Disc's rare disease drug despite commissioner's voucher
    17 hours ago
  • Drug Channels
    The Key to a Better Patient Experience: Improved GTN
    19 hours ago
  • FiercePharma
    Lilly's pre-launch inventory of oral GLP-1 candidate swells ahead of expected FDA obesity nod
    19 hours ago
  • Drug & Device Law
    The Zantac Defense Has the Hammer in Delaware
    20 hours ago
  • Science-Based Medicine
    The FDA: Promoting Quack Nostrums Based on “Incredible Stories” While Rejecting Vaccines Despite Successful RCTs
    21 hours ago
  • JD Supra Law News
    Surveillance Pricing: A Burgeoning Privacy Issue
    1 day ago
  • FDA What's New: Drugs
    Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers - 04/15/2026
    1 day ago
  • FDA - Press Releases
    FDA Approves Labeling Changes to Menopausal Hormone Therapy Products
    1 day ago
  • Asbestos and Mesothelioma News
    Proposed Peritoneal Mesothelioma Staging Could Fill Critical Gap
    1 day ago
  • Pharmafile
    Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation
    1 day ago
  • Pharmafile - Mfg & Production
    iOrganBio appoints Karol Jarzabek as Chief Operating Officer
    1 day ago
  • CNBC Health Care
    Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start
    2 days ago
  • Marler Blog
    Proud to have another new member of the Marler Clark Team
    5 days ago
  • World Pharma - Breaking News
    Innovative ‘poop pills’ show promising results in clinical trials for multiple types of cancer
    1 week ago
  • Quality Matters
    Quality standards and regulatory predictability: A Q&A with USP — Part Two
    1 week ago
  • The Incidental Economist
    Massachusetts Led on Dementia Policy Once. Can it Lead Again?
    1 week ago
  • GEN Biotech News
    New $100M CIRM Initiative Centers Platform Approaches for Rare Genetic Diseases
    1 week ago
  • FDA - Health Fraud
    Umary contains hidden drug ingredients
    1 week ago
  • NPR Blogs: Shots - Health News Blog
    Flu shot recommendation for kids dropped just as the illness rages
    4 weeks ago
  • Ted Eytan, MD
    Brisbane, QLD 🇦🇺
    5 weeks ago
  • Healthcare Packaging
    Practical Waste Recycling at the Hospital Level: What Are the Odds?
    2 months ago
  • 33 Charts
    The AI coding arms race
    3 months ago
  • The Compliance and Ethics Blog
    Why Compliance Is the Cornerstone of Ethical Medical Billing
    3 months ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    7 months ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    8 months ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    8 months ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    8 months ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    10 months ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    11 months ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    11 months ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    1 year ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    1 year ago
  • Healthy Travel Blog
    Hello world!
    1 year ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    1 year ago
  • Eye on FDA
    FDA Adds New AdComm to Address Genetic Metabolic Diseases
    1 year ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    2 years ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    2 years ago
  • Medgadget
    Plant-Based Soft Medical Robots
    2 years ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    2 years ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    2 years ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    3 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    3 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    3 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    6 years ago
  • Clinical Correlations
    Talk to Your Doctor: Direct-to-Consumer Advertising of Prescription Drugs, Part 2
    15 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ▼  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ▼  June (2)
      • California Designated Representative Training Cour...
      • COVID-19 - How To Protect Yourself And Others - CD...
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ►  2013 (127)
    • ►  December (7)
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo